HMGB1 and neoplasm: Previous studies have demonstrated that RT and immunotherapy may exert synergistic effects through the following mechanisms (10): (a) Exposure of tumor antigen and activation of antigen-presenting cells: RT induces immunogenic cell stress or immunogenic cell death in cancer cells, exposing calreticulin on their plasma membrane and releasing adenosine triphosphate (ATP) and HMGB1.